ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 139 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 3.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,443,000 | -34.3% | 172,370 | -29.8% | 0.02% | -42.3% |
Q1 2017 | $2,195,000 | +1951.4% | 245,563 | +1453.2% | 0.03% | +2500.0% |
Q3 2016 | $107,000 | -71.2% | 15,810 | -84.9% | 0.00% | -75.0% |
Q2 2016 | $372,000 | -17.3% | 104,388 | -2.2% | 0.00% | -20.0% |
Q4 2015 | $450,000 | -53.0% | 106,714 | -60.2% | 0.01% | -66.7% |
Q3 2014 | $958,000 | -43.3% | 268,332 | -27.5% | 0.02% | -42.3% |
Q2 2014 | $1,689,000 | +16.8% | 370,284 | +20.4% | 0.03% | +8.3% |
Q1 2014 | $1,446,000 | +21.9% | 307,577 | +29.9% | 0.02% | +33.3% |
Q4 2013 | $1,186,000 | +400.4% | 236,821 | +522.1% | 0.02% | +260.0% |
Q3 2013 | $237,000 | +144.3% | 38,071 | +78.3% | 0.01% | +150.0% |
Q2 2013 | $97,000 | – | 21,348 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |